SIMCERE PHARMACEUTICAL GROUP Deferred Tax Assets, Net of Valuation Allowance
SIMCERE PHARMACEUTICAL GROUP had Deferred Tax Assets, Net of Valuation Allowance of CNY 156.08 million as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2013-04-26
- 2012-12-31: Deferred Tax Assets, Net of Valuation Allowance 156.08M CNY.
- 2011-12-31: Deferred Tax Assets, Net of Valuation Allowance 131.68M CNY.
CNY
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2012-12-31 | 156.08M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 131.68M CNY 20-F · filed 2013-04-26 |
USD
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2012-12-31 | $25.05M 20-F · filed 2013-04-26 |